Global Low Molecular Weight Heparin Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Executive Summary
According to GRD Survey data, the global Low Molecular Weight Heparin market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.
This report studies the Low Molecular Weight Heparin market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Low Molecular Weight Heparin in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine
Market Snapshot, By Application
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others
Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia
Main Market Players Analyzed in this report, including:
Yantai Dongcheng Pharmaceutical Group
Techdow
Sanofi-aventis
Pfizer
Opocrin
Dongying Tiandong Pharmaceutical
CSBIO
Changzhou Qianhong Bio-pharma
Aspen
The study objectives of this report are:
To study and analyze the global Low Molecular Weight Heparin market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Low Molecular Weight Heparin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Low Molecular Weight Heparin manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Low Molecular Weight Heparin market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Low Molecular Weight Heparin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Low Molecular Weight Heparin are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Low Molecular Weight Heparin Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Low Molecular Weight Heparin Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Low Molecular Weight Heparin
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Low Molecular Weight Heparin Sales Channel and Distributors Analysis
3.3.1 Low Molecular Weight Heparin Sales Channel
3.3.2 Low Molecular Weight Heparin Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Low Molecular Weight Heparin Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Low Molecular Weight Heparin Type Introduction
4.1.1 Enoxaparin
4.1.2 Dalteparin
4.1.3 Tinzaparin
4.1.4 Fraxiparine
4.2 Global Low Molecular Weight Heparin Sales by Type 2016-2021
4.3 Global Low Molecular Weight Heparin Revenue by Type 2016-2021
4.4 Global Low Molecular Weight Heparin Price by Type 2016-2021
5 Market Segment: by Application
5.1 Low Molecular Weight Heparin Type Introduction
5.1.1 Treatment of Venous Thromboembolism
5.1.2 Complications of Pregnancy
5.1.3 Cardioversion of Atrial Fibrillation/Flutter
5.1.3 Others
5.2 Global Low Molecular Weight Heparin Sales by Application 2016-2021
5.3 Global Low Molecular Weight Heparin Revenue by Application 2016-2021
5.4 Global Low Molecular Weight Heparin Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Low Molecular Weight Heparin Market by Region
6.1.1 Global Low Molecular Weight Heparin Sales by Regions
6.1.2 Global Low Molecular Weight Heparin Revenue by Regions
6.2 North America Low Molecular Weight Heparin Market 2016-2021
6.3 Europe Low Molecular Weight Heparin Market 2016-2021
6.4 Asia Pacific Low Molecular Weight Heparin Market 2016-2021
6.5 South America Low Molecular Weight Heparin Market 2016-2021
6.6 Middle East and Africa Low Molecular Weight Heparin Market 2016-2021
7 North America
7.1 North America Low Molecular Weight Heparin Market by Country 2016-2021
7.1.1 North America Low Molecular Weight Heparin Sales by Country
7.1.2 North America Low Molecular Weight Heparin Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Low Molecular Weight Heparin Market by Country 2016-2021
8.1.1 Europe Low Molecular Weight Heparin Sales by Country
8.1.2 Europe Low Molecular Weight Heparin Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Low Molecular Weight Heparin Market by Country 2016-2021
9.1.1 Asia Pacific Low Molecular Weight Heparin Sales by Country
9.1.2 Asia Pacific Low Molecular Weight Heparin Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Low Molecular Weight Heparin Market by Country 2016-2021
10.1.1 South America Low Molecular Weight Heparin Sales by Country
10.1.2 South America Low Molecular Weight Heparin Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Low Molecular Weight Heparin Market by Country 2016-2021
11.1.1 Middle East and Africa Low Molecular Weight Heparin Sales by Country
11.1.2 Middle East and Africa Low Molecular Weight Heparin Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Yantai Dongcheng Pharmaceutical Group
12.1.1 Yantai Dongcheng Pharmaceutical Group Company Information
12.1.2 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Product Portfolio, Specification and Application
12.1.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Yantai Dongcheng Pharmaceutical Group Key Development
12.2 Techdow
12.2.1 Techdow Company Information
12.2.2 Techdow Low Molecular Weight Heparin Product Portfolio, Specification and Application
12.2.3 Techdow Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Techdow Key Development
12.3 Sanofi-aventis
12.3.1 Sanofi-aventis Company Information
12.3.2 Sanofi-aventis Low Molecular Weight Heparin Product Portfolio, Specification and Application
12.3.3 Sanofi-aventis Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Sanofi-aventis Key Development
12.4 Pfizer
12.4.1 Pfizer Company Information
12.4.2 Pfizer Low Molecular Weight Heparin Product Portfolio, Specification and Application
12.4.3 Pfizer Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Pfizer Key Development
12.5 Opocrin
12.5.1 Opocrin Company Information
12.5.2 Opocrin Low Molecular Weight Heparin Product Portfolio, Specification and Application
12.5.3 Opocrin Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Opocrin Key Development
12.6 Dongying Tiandong Pharmaceutical
12.6.1 Dongying Tiandong Pharmaceutical Company Information
12.6.2 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Product Portfolio, Specification and Application
12.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Dongying Tiandong Pharmaceutical Key Development
12.7 CSBIO
12.7.1 CSBIO Company Information
12.7.2 CSBIO Low Molecular Weight Heparin Product Portfolio, Specification and Application
12.7.3 CSBIO Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Dongying Tiandong Pharmaceutical Key Development
12.9 Aspen
12.9.1 Aspen Company Information
12.9.2 Aspen Low Molecular Weight Heparin Product Portfolio, Specification and Application
12.9.3 Aspen Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Aspen Key Development
12.8.1 Changzhou Qianhong Bio-pharma Company Information
12.8.2 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Product Portfolio, Specification and Application
12.8.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Changzhou Qianhong Bio-pharma Key Development
13 Global Low Molecular Weight Heparin Market Forecast by Region by Type and by Application
13.1 Global Low Molecular Weight Heparin Sales, Revenue Forecast 2022-2027
13.2 Global Low Molecular Weight Heparin Forecast by Regions
13.2.1 Global Low Molecular Weight Heparin Sales Forecast by Region 2022-2027
13.2.2 Global Low Molecular Weight Heparin Revenue Forecast by Region 2022-2027
13.3 Global Low Molecular Weight Heparin Forecast by Type
13.3.1 Global Low Molecular Weight Heparin Sales Forecast by Type 2022-2027
13.3.2 Global Low Molecular Weight Heparin Revenue Forecast by Type 2022-2027
13.3.3 Global Low Molecular Weight Heparin Price Forecast by Type 2022-2027
13.4 Global Low Molecular Weight Heparin Forecast by Application
13.4.1 Global Low Molecular Weight Heparin Sales Forecast by Application 2022-2027
13.4.2 Global Low Molecular Weight Heparin Revenue Forecast by Application 2022-2027
13.4.3 Global Low Molecular Weight Heparin Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
List of Tables
Table 1: Global Low Molecular Weight Heparin Production Specifications
Table 2: Drivers in Low Molecular Weight Heparin Market
Table 3: Restraints Low Molecular Weight Heparin Market
Table 4: Opportunity in Low Molecular Weight Heparin Market
Table 5: Comparion of Alternative and Low Molecular Weight Heparin
Table 6: Low Molecular Weight Heparin Raw Materials Key Suppliers List
Table 7: Low Molecular Weight Heparin Distributors List
Table 8: Low Molecular Weight Heparin Major Buyers in Application One
Table 9: Low Molecular Weight Heparin Major Buyers in Application Two
Table 10: Low Molecular Weight Heparin Major Buyers in Application Three
Table 11: Global Low Molecular Weight Heparin Sales (K Units) by Type 2016-2021
Table 12: Global Low Molecular Weight Heparin Sales Market Share by Type 2016-2021
Table 13: Global Low Molecular Weight Heparin Revenue (Million USD) by Type 2016-2021
Table 14: Global Low Molecular Weight Heparin Revenue Market Share by Type 2016-2021
Table 15: Global Low Molecular Weight Heparin Price by Type 2016-2021
Table 16: Global Low Molecular Weight Heparin Sales (K Units) by Application 2016-2021
Table 17: Global Low Molecular Weight Heparin Sales Market Share by Application 2016-2021
Table 18: Global Low Molecular Weight Heparin Revenue (Million USD) by Application 2016-2021
Table 19: Global Low Molecular Weight Heparin Revenue Market Share by Application 2016-2021
Table 20: Global Low Molecular Weight Heparin Price by Application 2016-2021
Table 21: Global Low Molecular Weight Heparin Sales (K Units) by Region 2016-2021
Table 22: Global Low Molecular Weight Heparin Sales Market Share by Region 2016-2021
Table 23: Global Low Molecular Weight Heparin Revenue (Million USD) by Region 2016-2021
Table 24: Global Low Molecular Weight Heparin Revenue Market Share by Region 2016-2021
Table 25: North America Low Molecular Weight Heparin Sales (K Units) by Country 2016-2021
Table 26: North America Low Molecular Weight Heparin Sales Market Share by Country 2016-2021
Table 27: North America Low Molecular Weight Heparin Revenue (Million USD) by Country 2016-2021
Table 28: North America Low Molecular Weight Heparin Revenue Market Share by Country 2016-2021)
Table 29: Europe Low Molecular Weight Heparin Sales (K Units) by Country 2016-2021
Table 30: Europe Low Molecular Weight Heparin Sales Market Share by Country 2016-2021
Table 31: Europe Low Molecular Weight Heparin Revenue (Million USD) by Country 2016-2021
Table 32: Europe Low Molecular Weight Heparin Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Low Molecular Weight Heparin Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Low Molecular Weight Heparin Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Low Molecular Weight Heparin Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Low Molecular Weight Heparin Revenue Market Share by Country 2016-2021)
Table 37: South America Low Molecular Weight Heparin Sales (K Units) by Country 2016-2021
Table 38: South America Low Molecular Weight Heparin Sales Market Share by Country 2016-2021
Table 39: South America Low Molecular Weight Heparin Revenue (Million USD) by Country 2016-2021
Table 40: South America Low Molecular Weight Heparin Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Low Molecular Weight Heparin Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Low Molecular Weight Heparin Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Low Molecular Weight Heparin Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Low Molecular Weight Heparin Revenue Market Share by Country 2016-2021)
Table 45 Yantai Dongcheng Pharmaceutical Group Company Information
Table 46 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Product Portfolio, Specification and Application
Table 47 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Techdow Company Information
Table 49 Techdow Low Molecular Weight Heparin Product Portfolio, Specification and Application
Table 50 Techdow Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Sanofi-aventis Company Information
Table 52 Sanofi-aventis Low Molecular Weight Heparin Product Portfolio, Specification and Application
Table 53 Sanofi-aventis Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Pfizer Company Information
Table 55 Pfizer Low Molecular Weight Heparin Product Portfolio, Specification and Application
Table 56 Pfizer Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Opocrin Company Information
Table 58 Opocrin Low Molecular Weight Heparin Product Portfolio, Specification and Application
Table 59 Opocrin Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Dongying Tiandong Pharmaceutical Company Information
Table 61 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Product Portfolio, Specification and Application
Table 62 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 CSBIO Company Information
Table 64 CSBIO Low Molecular Weight Heparin Product Portfolio, Specification and Application
Table 65 CSBIO Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Changzhou Qianhong Bio-pharma Company Information
Table 67 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Product Portfolio, Specification and Application
Table 68 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 Aspen Company Information
Table 70 Aspen Low Molecular Weight Heparin Product Portfolio, Specification and Application
Table 71 Aspen Low Molecular Weight Heparin Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Low Molecular Weight Heparin Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Low Molecular Weight Heparin Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Low Molecular Weight Heparin Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Low Molecular Weight Heparin Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Low Molecular Weight Heparin Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Low Molecular Weight Heparin Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Low Molecular Weight Heparin Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Low Molecular Weight Heparin Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Low Molecular Weight Heparin Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Low Molecular Weight Heparin Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Low Molecular Weight Heparin Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Low Molecular Weight Heparin Revenue Market Share Forecast by Application (2022-2027)
Tables and Figures
List of Figures
Figure 1: Low Molecular Weight Heparin Picture
Figure 2: Global Low Molecular Weight Heparin Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Low Molecular Weight Heparin Supply Chain Analysis
Figure 5: Low Molecular Weight Heparin Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Enoxaparin
Figure 7: Product Picture of Dalteparin
Figure 8: Global Low Molecular Weight Heparin Sales Market Share by Type, 2020
Figure 9: Global Low Molecular Weight Heparin Revenue Market Share by Type, 2020
Figure 10: Low Molecular Weight Heparin in Treatment of Venous Thromboembolism
Figure 11: Global Low Molecular Weight Heparin Market: Treatment of Venous Thromboembolism 2016-2021
Figure 12: Low Molecular Weight Heparin in Complications of Pregnancy
Figure 13: Global Low Molecular Weight Heparin Market: Complications of Pregnancy 2016-2021
Figure 14: Global Low Molecular Weight Heparin Sales Market Share by Application, 2020
Figure 15: Global Low Molecular Weight Heparin Revenue Market Share by Application, 2020
Figure 16: Global Low Molecular Weight Heparin Sales Market Share by Region 2016-2021
Figure 17: Global Low Molecular Weight Heparin Revenue Market Share by Region 2016-2021
Figure 18: North America Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 19: North America Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 20: Europe Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 21: Europe Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 24: South America Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 25: South America Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 28: North America Low Molecular Weight Heparin Sales Market Share by Country, 2020
Figure 29: North America Low Molecular Weight Heparin Revenue Market Share by Country, 2020
Figure 30: United States Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 31: United States Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 32: Canada Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 33: Canada Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 35: Mexico Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 36: Europe Low Molecular Weight Heparin Sales Market Share by Country, 2020
Figure 37: Europe Low Molecular Weight Heparin Revenue Market Share by Country, 2020
Figure 38: Germany Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 39: Germany Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 40: France Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 41: France Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 42: UK Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 43: UK Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 44: Italy Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 45: Italy Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 46: Russia Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 46: Russia Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 47: Spain Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 48: Spain Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Low Molecular Weight Heparin Sales Market Share by Country, 2020
Figure 50: Asia Pacific Low Molecular Weight Heparin Revenue Market Share by Country, 2020
Figure 51: China Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 52: China Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 53: Japan Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 54: Japan Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 55: Korea Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 56: Korea Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 59: India Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 60: India Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 61: Australia Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 62: Australia Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 63: South America Low Molecular Weight Heparin Sales Market Share by Country, 2020
Figure 64: South America Low Molecular Weight Heparin Revenue Market Share by Country, 2020
Figure 65: Brazil Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 66: Brazil Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 68: Argentina Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 70: Colombia Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Low Molecular Weight Heparin Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Low Molecular Weight Heparin Revenue Market Share by Country, 2020
Figure 73: Turkey Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 74: Turkey Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Low Molecular Weight Heparin Sales (K Units) Status 2016-2021
Figure 78: South Africa Low Molecular Weight Heparin Revenue (Million USD) Status 2016-2021
Figure 79: Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Revenue Market Share Globally (2019-2021)
Figure 80: Techdow Low Molecular Weight Heparin Revenue Market Share Globally (2019-2021)
Figure 81: Sanofi-aventis Low Molecular Weight Heparin Revenue Market Share Globally (2019-2021)
Figure 82: Pfizer Low Molecular Weight Heparin Revenue Market Share Globally (2019-2021)
Figure 83: Opocrin Low Molecular Weight Heparin Revenue Market Share Globally (2019-2021)
Figure 84: Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Revenue Market Share Globally (2019-2021)
Figure 85: CSBIO Low Molecular Weight Heparin Revenue Market Share Globally (2019-2021)
Figure 86: Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Revenue Market Share Globally (2019-2021)
Figure 87: Aspen Low Molecular Weight Heparin Revenue Market Share Globally (2019-2021)
Figure 89: Global Low Molecular Weight Heparin Sales (K Units) Forecast (2022-2027)
Figure 90: Global Low Molecular Weight Heparin Sales (K Units) Forecast (2022-2027)
Reason to Buy
- Current and future of Chemical & Material Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Chemical & Material Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Chemical & Material Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Chemical & Material Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets